Cochlear Nucleus Transcriptome of a Fragile X Mouse Model Reveals Candidate Genes for Hyperacusis

Abstract

ObjectiveFragile X Syndrome (FXS) is a hereditary form of autism spectrum disorder. It is caused by a trinucleotide repeat expansion in the Fmr1 gene, leading to a loss of Fragile X Protein (FMRP) expression. The loss of FMRP causes auditory hypersensitivity: FXS patients display hyperacusis and the Fmr1‐ knock‐out (KO) mouse model for FXS exhibits auditory seizures. FMRP is strongly expressed in the cochlear nucleus and other auditory brainstem nuclei. We hypothesize that the Fmr1‐KO mouse has altered gene expression in the cochlear nucleus that may contribute to auditory hypersensitivity.MethodsRNA was isolated from cochlear nuclei of Fmr1‐KO and WT mice. Using next‐generation sequencing (RNA‐seq), the transcriptomes of Fmr1‐KO mice and WT mice (n = 3 each) were compared and analyzed using gene ontology programs.ResultsWe identified 270 unique, differentially expressed genes between Fmr1‐KO and WT cochlear nuclei. Upregulated genes (67%) are enriched in those encoding secreted molecules. Downregulated genes (33%) are enriched in neuronal function, including synaptic pathways, some of which are ideal candidate genes that may contribute to hyperacusis.ConclusionThe loss of FMRP can affect the expression of genes in the cochlear nucleus that are important for neuronal signaling. One of these, Kcnab2, which encodes a subunit of the Shaker voltage‐gated potassium channel, is expressed at an abnormally low level in the Fmr1‐KO cochlear nucleus. Kcnab2 and other differentially expressed genes may represent pathways for the development of hyperacusis. Future studies will be aimed at investigating the effects of these altered genes on hyperacusis.Level of EvidenceLevel N/A Laryngoscope, 2023